PAR DRUGS AND CHEMICALS
|
PAR DRUGS AND CHEMICALS Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹6.15 Cr | ₹6.15 Cr |
Equity - Authorised | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹8.75 Cr | ₹8.75 Cr |
Equity - Issued | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹6.15 Cr | ₹6.15 Cr |
Equity Paid Up | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹6.15 Cr | ₹6.15 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹73 Cr | ₹59 Cr | ₹48 Cr | ₹46 Cr | ₹34 Cr |
Securities Premium | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹17 Cr | ₹17 Cr |
Capital Reserves | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
Profit & Loss Account Balance | ₹63 Cr | ₹48 Cr | ₹37 Cr | ₹29 Cr | ₹18 Cr |
General Reserves | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹73 Cr | ₹59 Cr | ₹48 Cr | ₹46 Cr | ₹34 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹86 Cr | ₹71 Cr | ₹60 Cr | ₹52 Cr | ₹41 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | ₹0.59 Cr | ₹0.61 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | ₹1.25 Cr | ₹1.86 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | ₹-0.66 Cr | ₹-1.25 Cr |
Unsecured Loans | - | - | - | ₹3.80 Cr | ₹4.01 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | ₹3.80 Cr | ₹4.01 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹3.54 Cr | ₹3.50 Cr | ₹3.55 Cr | ₹3.41 Cr | ₹3.65 Cr |
Deferred Tax Assets | ₹0.04 Cr | ₹0.07 Cr | ₹0.12 Cr | ₹0.14 Cr | ₹0.13 Cr |
Deferred Tax Liability | ₹3.58 Cr | ₹3.57 Cr | ₹3.67 Cr | ₹3.55 Cr | ₹3.78 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | ₹0.14 Cr | ₹0.41 Cr | ₹0.39 Cr | ₹0.39 Cr |
Total Non-Current Liabilities | ₹3.54 Cr | ₹3.64 Cr | ₹3.96 Cr | ₹8.19 Cr | ₹8.66 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹5.36 Cr | ₹8.09 Cr | ₹11 Cr | ₹6.72 Cr | ₹6.21 Cr |
Sundry Creditors | ₹5.36 Cr | ₹8.09 Cr | ₹11 Cr | ₹6.72 Cr | ₹6.21 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹1.94 Cr | ₹1.98 Cr | ₹0.80 Cr | ₹2.47 Cr | ₹2.69 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹0.01 Cr | ₹0.06 Cr | ₹0.01 Cr | - | ₹0.02 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹1.93 Cr | ₹1.92 Cr | ₹0.79 Cr | ₹2.47 Cr | ₹2.67 Cr |
Short Term Borrowings | - | - | - | ₹3.25 Cr | - |
Secured ST Loans repayable on Demands | - | - | - | ₹3.25 Cr | - |
Working Capital Loans- Sec | - | - | - | ₹3.25 Cr | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | ₹-3.25 Cr | - |
Short Term Provisions | ₹5.14 Cr | ₹3.92 Cr | ₹3.40 Cr | ₹3.55 Cr | ₹1.95 Cr |
Proposed Equity Dividend | - | - | - | - | ₹0.77 Cr |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹4.98 Cr | ₹3.80 Cr | ₹3.35 Cr | ₹3.36 Cr | ₹1.00 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.17 Cr | ₹0.12 Cr | ₹0.05 Cr | ₹0.19 Cr | ₹0.18 Cr |
Total Current Liabilities | ₹12 Cr | ₹14 Cr | ₹15 Cr | ₹16 Cr | ₹11 Cr |
Total Liabilities | ₹102 Cr | ₹89 Cr | ₹79 Cr | ₹76 Cr | ₹60 Cr |
ASSETS | |||||
Gross Block | ₹74 Cr | ₹68 Cr | ₹60 Cr | ₹53 Cr | ₹57 Cr |
Less: Accumulated Depreciation | ₹33 Cr | ₹29 Cr | ₹26 Cr | ₹23 Cr | ₹23 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹41 Cr | ₹38 Cr | ₹34 Cr | ₹30 Cr | ₹34 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹0.03 Cr | ₹0.25 Cr | ₹0.25 Cr | ₹4.52 Cr | ₹0.74 Cr |
Non Current Investments | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.06 Cr |
Long Term Investment | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.06 Cr |
Quoted | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | - |
Unquoted | - | - | - | - | ₹0.06 Cr |
Long Term Loans & Advances | ₹0.64 Cr | ₹0.73 Cr | ₹0.77 Cr | ₹0.76 Cr | ₹0.71 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹42 Cr | ₹39 Cr | ₹35 Cr | ₹35 Cr | ₹36 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹4.18 Cr | ₹5.38 Cr | ₹4.71 Cr | ₹3.00 Cr | ₹2.92 Cr |
Raw Materials | ₹0.38 Cr | ₹0.92 Cr | ₹1.24 Cr | ₹0.41 Cr | ₹0.59 Cr |
Work-in Progress | ₹0.20 Cr | ₹0.65 Cr | ₹0.23 Cr | ₹0.53 Cr | ₹0.07 Cr |
Finished Goods | ₹3.09 Cr | ₹3.11 Cr | ₹2.83 Cr | ₹1.75 Cr | ₹1.99 Cr |
Packing Materials | ₹0.29 Cr | ₹0.39 Cr | ₹0.23 Cr | ₹0.24 Cr | ₹0.19 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹0.21 Cr | ₹0.31 Cr | ₹0.19 Cr | ₹0.08 Cr | ₹0.08 Cr |
Sundry Debtors | ₹14 Cr | ₹17 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr |
Debtors more than Six months | ₹0.12 Cr | ₹1.22 Cr | ₹0.60 Cr | ₹0.02 Cr | ₹0.00 Cr |
Debtors Others | ₹14 Cr | ₹16 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr |
Cash and Bank | ₹37 Cr | ₹22 Cr | ₹16 Cr | ₹21 Cr | ₹7.38 Cr |
Cash in hand | ₹0.02 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹0.02 Cr |
Balances at Bank | ₹37 Cr | ₹22 Cr | ₹16 Cr | ₹21 Cr | ₹7.36 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.04 Cr | ₹0.04 Cr | ₹0.12 Cr | ₹0.19 Cr | ₹0.06 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | ₹0.02 Cr | ₹0.02 Cr |
Prepaid Expenses | ₹0.04 Cr | ₹0.04 Cr | ₹0.05 Cr | ₹0.06 Cr | ₹0.05 Cr |
Other current_assets | - | - | ₹0.07 Cr | ₹0.12 Cr | - |
Short Term Loans and Advances | ₹5.04 Cr | ₹4.80 Cr | ₹4.06 Cr | ₹4.38 Cr | ₹1.49 Cr |
Advances recoverable in cash or in kind | ₹0.24 Cr | ₹0.59 Cr | ₹0.79 Cr | ₹0.89 Cr | ₹0.57 Cr |
Advance income tax and TDS | ₹4.70 Cr | ₹4.14 Cr | ₹3.22 Cr | ₹3.46 Cr | ₹0.86 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹0.10 Cr | ₹0.08 Cr | ₹0.05 Cr | ₹0.03 Cr | ₹0.05 Cr |
Total Current Assets | ₹60 Cr | ₹49 Cr | ₹44 Cr | ₹41 Cr | ₹24 Cr |
Net Current Assets (Including Current Investments) | ₹47 Cr | ₹35 Cr | ₹29 Cr | ₹25 Cr | ₹13 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹102 Cr | ₹89 Cr | ₹79 Cr | ₹76 Cr | ₹60 Cr |
Contingent Liabilities | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.24 Cr | ₹0.24 Cr |
Total Debt | - | - | - | ₹8.32 Cr | ₹6.01 Cr |
Book Value | 69.59 | 57.90 | 48.66 | 84.87 | 66.02 |
Adjusted Book Value | 69.59 | 57.90 | 48.66 | 42.44 | 33.01 |
Compare Balance Sheet of peers of PAR DRUGS AND CHEMICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PAR DRUGS AND CHEMICALS | ₹247.8 Cr | 2.6% | -0.4% | -1.6% | Stock Analytics | |
PIDILITE INDUSTRIES | ₹145,669.0 Cr | 4% | -1.7% | 10.7% | Stock Analytics | |
SOLAR INDUSTRIES INDIA | ₹83,727.3 Cr | -0.6% | -3.3% | 40.5% | Stock Analytics | |
SRF | ₹77,070.5 Cr | 3.1% | 15.7% | 12.4% | Stock Analytics | |
GUJARAT FLUOROCHEMICALS | ₹36,734.4 Cr | -9.1% | -19% | -2.2% | Stock Analytics | |
DEEPAK NITRITE | ₹29,912.4 Cr | -5.3% | -12.7% | -3% | Stock Analytics |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PAR DRUGS AND CHEMICALS | 2.6% |
-0.4% |
-1.6% |
SENSEX | 0.1% |
-3.6% |
7.9% |
You may also like the below Video Courses